On January 15, 2025, the Department of Health and Human Services (HHS) and Drug Enforcement Administration (DEA) issued a series of rules relating ...

The Drug Enforcement Administration ("DEA") announced three new regulations related to the prescription of controlled substances resulting from ...

Opens in a new tab or window Physicians would have to register with the Drug Enforcement Administration (DEA ... III-V controlled substances would need to apply for a special registration ...

The Drug Enforcement Administration released a notice of proposed rulemaking that would create a three-tiered special registration ... II-V controlled substances with the DEA.

Now, the DEA has released a potential ... to prescribe Schedule II to V controlled substances. Providers would also have to maintain a state telemedicine registration for each state they practice ...

For about half a decade now, Americans have had the ability to receive controlled substances via telehealth because requirements were relaxed during the Covid-19 pandemic. This has greatly ...

Healthcare providers will finally get a special registration to dispense controlled ... verification, electronic recordkeeping, and ongoing monitoring.” “We are pleased to see the DEA propose ...

On Wednesday, the DEA released a proposed rule that would set up a special registration process for remote prescribing of Schedule II-V controlled substances such as Xanax, Vicodin and Adderall.

Physicians would have to register with the Drug Enforcement Administration (DEA ... prescribe Schedule III-V controlled substances would need to apply for a special registration; substances ...

Congress first directed the DEA to create the special registration program in 2008. That law prevented providers from prescribing controlled substances through telehealth unless they received such ...